Natera Retained Earnings (Accumulated Deficit) 2014-2024 | NTRA
Natera retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Natera retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-2.514B, a 9.34% increase year-over-year.
- Natera retained earnings (accumulated deficit) for 2023 were $-2.377B, a 22.38% increase from 2022.
- Natera retained earnings (accumulated deficit) for 2022 were $-1.943B, a 39.27% increase from 2021.
- Natera retained earnings (accumulated deficit) for 2021 were $-1.395B, a 50.09% increase from 2020.
| Natera Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-2,377 |
| 2022 | $-1,943 |
| 2021 | $-1,395 |
| 2020 | $-929 |
| 2019 | $-699 |
| 2018 | $-575 |
| 2017 | $-446 |
| 2016 | $-346 |
| 2015 | $-250 |
| 2014 | $-180 |
| 2013 | $-175 |
| Natera Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-2,514 |
| 2024-06-30 | $-2,482 |
| 2024-03-31 | $-2,445 |
| 2023-12-31 | $-2,377 |
| 2023-09-30 | $-2,299 |
| 2023-06-30 | $-2,190 |
| 2023-03-31 | $-2,080 |
| 2022-12-31 | $-1,943 |
| 2022-09-30 | $-1,800 |
| 2022-06-30 | $-1,679 |
| 2022-03-31 | $-1,533 |
| 2021-12-31 | $-1,395 |
| 2021-09-30 | $-1,254 |
| 2021-06-30 | $-1,103 |
| 2021-03-31 | $-987 |
| 2020-12-31 | $-929 |
| 2020-09-30 | $-853 |
| 2020-06-30 | $-795 |
| 2020-03-31 | $-735 |
| 2019-12-31 | $-699 |
| 2019-09-30 | $-664 |
| 2019-06-30 | $-641 |
| 2019-03-31 | $-608 |
| 2018-12-31 | $-575 |
| 2018-09-30 | $-543 |
| 2018-06-30 | $-513 |
| 2018-03-31 | $-479 |
| 2017-12-31 | $-446 |
| 2017-09-30 | $-437 |
| 2017-06-30 | $-410 |
| 2017-03-31 | $-382 |
| 2016-12-31 | $-346 |
| 2016-09-30 | $-308 |
| 2016-06-30 | $-282 |
| 2016-03-31 | $-259 |
| 2015-12-31 | $-250 |
| 2015-09-30 | $-227 |
| 2015-06-30 | $-209 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2013-12-31 | $-175 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.788B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| Elevance Health (ELV) | United States | $90.846B | 11.88 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |